The following paper was accepted for publication
-
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody - OS2966.
Lapteva M, Del Río-Sancho S, Wu E, Carbonell WS, Böhler C, Kalia YN.
Sci Rep. 2019 Jan 31;9(1):1030. doi: 10.1038/s41598-018-36966-0.
-
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
Lapteva M, Mignot M, Mondon K, Möller M, Gurny R, Kalia YN.
Eur J Pharm Biopharm. 2019 Jan 12. pii: S0939-6411(18)31203-7. doi: 10.1016/j.ejpb.2019.01.008.
[Epub ahead of print]